术前电针预防腹腔镜妇科手术后恶心呕吐的随机对照试验
该随机对照试验纳入413例择期腹腔镜妇科手术患者,比较术前不同时间点电针与常规护理对术后恶心呕吐(PONV)及疼痛的影响。结果显示电针组在6-24小时恶心呕吐发生率、0-48小时止吐药使用及0-6小时疼痛评分上均低于常规组,三种电针方案间无显著差异。
要点
- 术前电针可降低6-24小时恶心呕吐发生率,常规/术前1天/术前30分钟/联合组分别为28/11/18/11%。
- 术前电针减少0-48小时止吐药使用及0-6小时疼痛评分,电针组间无显著差异。
- 单次术前电针可作为多模式止吐方案的安全辅助措施。
核心结论
- 在腹腔镜妇科手术患者中,单次术前电针可能是预防PONV的安全辅助治疗。
- 电针的最佳时机仍需进一步验证。
研究设计与样本
- 随机对照试验,共413例择期腹腔镜妇科手术患者,随机分为4组:术前1天电针组(n=103)、术前30分钟电针组(n=104)、联合组(n=103)和常规护理组(n=103)。
- 所有电针组均接受常规护理。
主要发现
- 6-24小时恶心发生率:常规/术前1天/术前30分钟/联合组分别为28%/11%/18%/11%(p=0.003)。
- 6-24小时呕吐发生率:常规/术前1天/术前30分钟/联合组分别为23%/5%/8%/9%(p<0.001)。
- 0-6小时恶心发生率:常规/术前1天/术前30分钟/联合组分别为20%/9%/11%/7%(p=0.013)。
- 0-6小时呕吐发生率:常规/术前1天/术前30分钟/联合组分别为17%/7%/9%/6%(p=0.021)。
- 0-6小时需补救止吐药比例:常规/术前1天/术前30分钟/联合组分别为18%/4%/11%/4%(p=0.001)。
临床怎么用
- 对于接受腹腔镜妇科手术且已使用多模式止吐方法的患者,可考虑术前给予单次电针作为辅助预防PONV。
- 电针时机选择术前1天、术前30分钟或两者联合均可,但最佳时机需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to evaluate the effectiveness and safety of preoperative electroacupuncture (EA) on the incidence of postoperative nausea and vomiting (PONV), and severity of postoperative pain, in gynecological patients undergoing laparoscopic surgery. The effects of EA administered at different preoperative time points were compared. METHODS: A total of 413 patients undergoing elective laparoscopic gynecological surgery were randomly allocated into 4 groups receiving EA the day before surgery (Group Pre, n = 103), 30 min before (Group 30, n = 104) or both (Group Comb, n = 103), or usual care alone (Group Usual, n = 103). All acupuncture groups had usual care. The incidence of PONV and pain at 24 h were primary outcomes. Secondary outcomes included the severity of postoperative nausea, vomiting and pain, requirement for antiemetic medication and quality of recovery (QoR)-15 scores after surgery. RESULTS: There were significant differences between the four groups in nausea and vomiting incidence (0-24 h), postoperative antiemetic use (0-48 h), and postoperative pain (0-6 h), with the EA groups recording the lowest levels. Regarding primary outcomes, incidence of nausea and vomiting at 6-24 h was 28/11/18/11% (p = 0.003) 23/5/8/9% (p < 0.001), respectively, for Groups Usual/Pre/30/Comb. Accordingly, EA reduced the incidence of nausea and vomiting at 6-24 h by 61/34/60% and 79/65/61% for Groups Pre/30/Comb, respectively. Regarding secondary outcomes, incidence of nausea and vomiting at 0-6 h was 20/9/11/7% (p = 0.013) and 17/7/9/6% (p = 0.021), respectively, for Groups Usual/Pre/30/Comb. Rescue antiemetics at 0-6 h were required by 18/4/11/4% (p = 0.001) in Groups Usual/Pre/30/Comb. The mean numerical rating scale (NRS) pain score (0-10) at 0-6 h was significantly different between groups (2.45/1.89/2.01/1.97 for Groups Usual/Pre/30/Comb, p = 0.024). There were no significant differences between the three EA-treated groups. CONCLUSION: In gynecological patients undergoing laparoscopic surgery and treated with multimodal antiemetic methods, one session of preoperative EA may be a safe adjunctive treatment for PONV prophylaxis. Optimal timing of EA requires further verification. TRIAL REGISTRATION NUMBER: ChiCTR-INR-16010035 (Chinese Clinical Trial Registry).
引用
- Zhu J, Li S, Wu W, et al. Preoperative electroacupuncture for postoperative nausea and vomiting in laparoscopic gynecological surgery: a randomized controlled trial. Acupunct Med. 2022. PMID: 35229627. doi:10.1177/09645284221076517
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。